Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart

This publication has 44 references indexed in Scilit:

• The role of Fas ligand in immune privilege
  Nature Reviews Molecular Cell Biology, 2001
• Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia
  The FASEB Journal, 2001
• Proinflammatory consequences of transgenic Fas ligand expression in the heart
  Journal of Clinical Investigation, 2000
• Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand–Induced Cell Death
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Adenovirus-Mediated Expression of Fas Ligand Induces Hepatic Apoptosis after Systemic Administration and Apoptosis ofEx Vivo-Infected Pancreatic Islet Allografts and Isografts
  Human Gene Therapy, 1997
• Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.
  Journal of Clinical Investigation, 1997
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
  Science, 1995
• A role for CD95 ligand in preventing graft rejection
  Nature, 1995
• Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative Disease
  Annual Review of Immunology, 1991
• Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.
  Circulation, 1983